How should I evaluate and manage a 57-year-old female presenting with a month of generalized weakness and malaise, mild microcytic anemia, borderline impaired renal function, mildly elevated liver enzymes, hypertension on amlodipine, intermittent asthma, and a history of kidney donation two years ago?

Approach to Microcytic Anemia with Borderline Renal Impairment in a Post-Kidney Donor

This patient requires immediate iron studies (ferritin and transferrin saturation) and evaluation for gastrointestinal blood loss, as her microcytic anemia (MCV 79.8, MCH 22.8, MCHC 28.7) most likely represents iron deficiency that must be investigated given her kidney donor status and borderline renal function (eGFR 63).

Initial Diagnostic Workup

Essential Iron Studies

The microcytic indices strongly suggest iron deficiency, which is the most common cause of microcytic anemia. Order immediately:

• Serum ferritin - In non-dialysis CKD patients, ferritin <11 ng/mL in females indicates insufficient iron stores 1
• Transferrin saturation (TSAT) - More reliable than ferritin in CKD as it's less affected by inflammation; TSAT <15% suggests iron deficiency 1
• Reticulocyte count - To assess bone marrow response; a low reticulocyte index in a CKD patient replete with iron and B12 suggests erythropoietin deficiency or inflammation 1

Critical Point About Her Kidney Donor Status

In non-dialysis CKD patients not on erythropoietic agents and without menstrual losses, finding iron deficiency mandates careful assessment for gastrointestinal bleeding 1. Given her history as a kidney donor 2 years ago, this is particularly important.

Evaluation for Blood Loss

Gastrointestinal Assessment

• Stool guaiac testing - Screen for occult GI bleeding 2
• Upper and lower endoscopy if iron deficiency confirmed - Iron deficiency in a postmenopausal woman (age 57) with no obvious source requires GI evaluation 3
• Helicobacter pylori testing - Can contribute to iron malabsorption 3
• Celiac serology - Malabsorption can cause iron deficiency 3

Medication Review

Her amlodipine is unlikely to cause anemia directly, though rare hematologic effects have been reported 4, 5. However, if she's taking NSAIDs or aspirin (not mentioned but common in hypertensive patients), these increase GI bleeding risk 6.

Addressing the Renal Function

eGFR 63 and Anemia

Her eGFR of 63 mL/min/1.73m² places her in CKD Stage 2-3a. While anemia prevalence increases as kidney function declines, her microcytic pattern suggests iron deficiency rather than erythropoietin deficiency (which typically causes normocytic anemia) 1.

Key consideration: As a kidney donor, her baseline eGFR should be reassessed. A single kidney typically functions at 70-80% of two-kidney GFR, so eGFR 63 may represent:

• Expected post-donation baseline
• Mild decline requiring investigation
• Measurement variability

Action: Compare to her immediate post-donation eGFR values and trend over the past 2 years.

Mildly Elevated Liver Enzymes

ALT 41.9 and AST 30.9 are minimally elevated. While amlodipine can rarely cause hepatotoxicity 7, 8, 9, these mild elevations more likely reflect:

• Fatty liver (given borderline metabolic parameters)
• Chronic disease/inflammation
• Medication effect (less likely at this level)

Monitor but do not attribute anemia to liver dysfunction at these levels.

Management Algorithm

If Iron Deficiency Confirmed (Ferritin <45 ng/dL, TSAT <15%):

1. Oral iron trial first 3:

   • Ferrous sulfate 325 mg daily (or alternate day dosing for better tolerance)
   • Take on empty stomach with vitamin C 500 mg
   • Recheck CBC, ferritin, TSAT in 4-6 weeks

2. If oral iron fails or not tolerated 3:

   • IV iron (200 mg weekly × 3 weeks) 10
   • Particularly appropriate given her CKD stage

3. GI evaluation mandatory if iron deficiency confirmed without obvious source 1, 3

If Iron Studies Normal:

Consider reticulocyte count to assess bone marrow response:

• Low reticulocyte index → Likely erythropoietin deficiency from CKD 1
• High reticulocyte index → Consider hemolysis or blood loss 2

Monitoring Her CKD

• Annual hemoglobin monitoring minimum for CKD patients 1
• More frequent if anemia worsens or eGFR declines
• Assess for CKD complications (already done: vitamin D adequate at 43.5, B12 replete at 928)

Common Pitfalls to Avoid

1. Don't assume anemia is from CKD alone - The microcytic pattern demands iron studies and GI evaluation 1
2. Don't overlook her donor status - Her "CKD" may be physiologic adaptation; compare to post-donation baseline
3. Don't start erythropoietin without excluding iron deficiency - Iron deficiency must be corrected first 10
4. Don't ignore ferritin 20-45 ng/mL range - In CKD with anemia, this may still represent functional iron deficiency requiring supplementation 3

Additional Considerations

Her HbA1c of 6% indicates prediabetes, which increases anemia risk in CKD 1. Her asthma treatment history should be reviewed for systemic corticosteroid use, which could affect bone marrow function, though this is less likely given normal B12 and adequate vitamin D.

The weakness and malaise will likely improve significantly once anemia is corrected, as these are classic symptoms of iron deficiency anemia affecting quality of life.